Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Tumor necrosis factor alpha but not interleukin 1 beta mediates neuroprotection in response to acute nitric oxide excitotoxicity.
UK multiple sclerosis risk-sharing scheme: a new natural history dataset and an improved Markov model.
Estrogen and testosterone therapies in multiple sclerosis.
A validated gene regulatory network and GWAS identifies early regulators of T cell-associated diseases.
Avonex approval application
A study comparing the effectiveness and safety of teriflunomide and interferon beta-1a in patients with relapsing multiple sclerosis (TENERE)
Smoking and increased risk of multiple sclerosis: parallel trends in the sex ratio reinforce the evidence.
Second International Porto Congress of Multiple Sclerosis
Episode 34 with Dr. Jill Hollenbach on killer immunoglobulin like (KIR) receptors
A phase 3 trial of extended release oral dalfampridine in multiple sclerosis.
Episode 29 with Dr. Monica Carson on MS research funding
Validation of the Brazilian version of the neurological fatigue index for multiple sclerosis.
Neuroscience 2014
American Academy of Neurology 2012 Annual Meeting
Cuprizone neurotoxicity in the rat: morphologic observations.
Sequential myelin protein expression during remyelination reveals fast and efficient repair after central nervous system demyelination.
Cerebrospinal fluid markers reveal intrathecal inflammation in progressive multiple sclerosis.
Adherence to Disease Modifying Drugs among Patients with Multiple Sclerosis in Germany: A Retrospective Cohort Study.
The Brain as a Target of Inflammatory Processes
Pathogen-induced human TH17 cells produce IFN-γ or IL-10 and are regulated by IL-1β.
Demyelination and remyelination in anatomically distinct regions of the corpus callosum following cuprizone intoxication.
Glia in Health & Disease
Delta-9-tetrahydrocannabinol/cannabidiol (sativex(®)): a review of its use in patients with moderate to severe spasticity due to multiple sclerosis.
Anti-Human Herpesvirus 6A/B IgG Correlates with Relapses and Progression in Multiple Sclerosis.
Microglia across the lifespan: from origin to function in brain development, plasticity and cognition.
Pages
« first
‹ previous
…
58
59
60
61
62
63
64
65
66
…
next ›
last »